<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03895736</url>
  </required_header>
  <id_info>
    <org_study_id>2019-A00239-48</org_study_id>
    <nct_id>NCT03895736</nct_id>
  </id_info>
  <brief_title>Transcriptome Assessment After Cardiac Arrest</brief_title>
  <acronym>OMECARD</acronym>
  <official_title>&quot; Etude du Transcriptome Complet Lors du Syndrome Post-arrêt Cardiaque &quot; Transcriptome Assessment After Cardiac Arrest</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Paris 5 - Rene Descartes</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Institut National de la Santé Et de la Recherche Médicale, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Université Paris Est Créteil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ecole Nationale Vétérinaire d’Alfort</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether the blood transcriptome of patients
      resuscitated after out-of-hospital could be an early predictor of the neurological outcome.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Assessing the prognosis of the patients resuscitated after out-of-hospital cardiac arrest
      (OHCA) is still highly challenging. Beyond usual neurological markers, experimental and
      clinical studies have also shown that blood levels of several cytokines or miRNA could be
      significantly different after cardiac arrest in subjects prematurely died as compared to
      survivors with a good neurological recovery. Here the investigators propose to investigate a
      screening approach assessing simultaneously multiple targets of the post-cardiac arrest
      syndrome through analysis of the whole transcriptome of patients after OHCA. For this
      purpose, the investigators will collect blood samples from 60 patients after admission at
      hospital and then 1 and 3 days later. The Pittsburgh Cerebral Performance Category of each
      patient will be evaluated for each patient at day 60 after cardiac arrest. At the end of the
      collection period, the blood samples will be prepared for whole genome analysis and RNA
      sequencing. The primary analysis of the investigators will be the comparison of the
      transcriptome at day 0 after cardiac arrest in patients reaching Cerebral Performance
      Category (CPC) 1 at day 60 as compared to all other patients.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">May 2019</start_date>
  <completion_date type="Anticipated">June 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Early Transcriptome at hospital admission</measure>
    <time_frame>Day 0</time_frame>
    <description>Blood samples will be collected for each patient early after admission at hospital and blood whole transcriptome will be assessed by RNA sequencing</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pittsburgh Cerebral Performance Category at Day 60</measure>
    <time_frame>Day 60</time_frame>
    <description>Pittsburgh Cerebral Performance Category will be evaluated for each patient at day 60</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Transcriptome at day 1</measure>
    <time_frame>Day 1</time_frame>
    <description>Blood samples will be collected for each patient at day 1 and blood whole transcriptome will be assessed by RNA sequencing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Transcriptome at day 3</measure>
    <time_frame>Day 3</time_frame>
    <description>Blood samples will be collected for each patient at day 3 and blood whole transcriptome will be assessed by RNA sequencing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Cerebral Performance Category at Day 28</measure>
    <time_frame>day 28</time_frame>
    <description>Pittsburgh Cerebral Performance Category will be evaluated for each patient at day 28</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with death at day 28</measure>
    <time_frame>day 28</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participants with death at day 60</measure>
    <time_frame>day 60</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Out-Of-Hospital Cardiac Arrest After Initial Successful Resuscitation</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sampling</intervention_name>
    <description>Sampling of 15 ml of blood during a blood test at Day 0, Day 1 and Day 3</description>
    <other_name>Blood sampling at Day 0, Day 1 and Day 3</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18 and 80 years

          -  Delay between patients collapse and resumption of spontaneous circulation (ROSC) &lt; 60
             minutes

          -  Comatose patients ROSC with Glasgow score &lt; 7

          -  Patient already registered in the social security system

          -  Consent of a family member, if able to understand in the emergency context, or
             attestation of emergency situation with a follow-up information notice

        Exclusion Criteria:

          -  Cardiac arrest supposed to be provoked by trauma or sepsis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alain Cariou, Prof.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Renaud Tissier, Prof</last_name>
    <role>Study Chair</role>
    <affiliation>Ecole Nationale Vétérinaire d’Alfort</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alain Cariou, Prof</last_name>
    <email>alain.cariou@aphp.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>ADELE BELLINO</last_name>
    <phone>00 33 1 58 41 11 95</phone>
    <email>adele.bellino@aphp.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hôpital Cochin, Assistance Publique Hôpitaux de Paris</name>
      <address>
        <city>Paris</city>
        <zip>75005</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>ADELE BELLINO</last_name>
      <phone>01.58.41.11.95</phone>
      <email>adele.bellino@aphp.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>March 21, 2019</study_first_submitted>
  <study_first_submitted_qc>March 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2019</study_first_posted>
  <last_update_submitted>April 1, 2019</last_update_submitted>
  <last_update_submitted_qc>April 1, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Transcriptome</keyword>
  <keyword>messenger ribonucleic acid (mRNA)</keyword>
  <keyword>sequencing</keyword>
  <keyword>biomarker</keyword>
  <keyword>cardiac arrest</keyword>
  <keyword>prognostication</keyword>
  <keyword>successful resuscitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Arrest</mesh_term>
    <mesh_term>Out-of-Hospital Cardiac Arrest</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

